Advertisement

21st International AIDS Conference (AIDS 2016)

News

Test and Treat Did Not Impact Transmission Rates in South African Study

August 15, 2016

On behalf of IFARA, Fred Schaich spoke with François Dabis, M.D., Ph.D., about a study presented at this year's International AIDS Conference on the impact of the "test and treat" strategy on HIV transmission rates. Everyone in 22 South African communities was offered at-home HIV testing, with 90% of those reached accepting the offer. In half the communities, those testing positive for the virus were offered immediate antiretroviral therapy and in the other half they were offered treatment according to national guidelines. About one-third of those tested in either group were infected with HIV, with one-third of those already on treatment. The rate of new HIV infections during the study period did not differ between the two sets of communities, mostly because few people were willing to start antiretroviral therapy immediately after testing positive. In addition, about one-quarter of the communities, mostly young men, could not be reached for HIV testing. However, similar studies in Kenya and Uganda have achieved better interim results, showing that solutions for engagement cannot readily be transferred across communities, Dabis concluded.

Watch the video to learn more:



About the panelist:

  • François Dabis, M.D., Ph.D., University of Bordeaux, France

The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the conference, as well as earlier meetings.

Barbara Jungwirth is a freelance writer and translator based in New York.

Follow Barbara on Twitter: @reliabletran.


Copyright © 2016 Remedy Health Media, LLC. All rights reserved.


Related Stories

Continued Access to Generic Drugs Needed to Enable 'Test and Treat' Strategy
HIV 'Test and Treat' Strategy Can Save Lives -- But It Needs to Be Easier for Patients to Start Treatment
HIV, AIDS and 90-90-90: What Is It and Why Does It Matter?



This article was provided by TheBodyPRO.com. It is a part of the publication The 21st International AIDS Conference (AIDS 2016).
 


No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.